CDER

Data management and digital tools are driving FDA’s efforts to respond to the next wave of COVID-19 demands.

Leveraging patient experience data for product development requires strong workforce readiness.

Leaders across the Center for Drug Evaluation and Research are applying lessons learned from the pandemic on its response to therapies for emerging variants.